IF by specialty › Gastroenterology & Hepatology
Alimentary Pharmacology & Therapeutics — Impact Factor
The 2025 Impact Factor of Alimentary Pharmacology & Therapeutics is 6.8 (Q1 in Gastroenterology & Hepatology; subscription or hybrid).
- Impact Factor
- 6.8 JCR 2025
- JCR category
- Gastroenterology & Hepatology
- Quartile
- Q1 in Gastroenterology & Hepatology
- Publisher
- Wiley
- Open access
- subscription or hybrid
- Abbreviations
- APT
- IF source
- bioxbio.com
Position within the field
Ranked 14 of the 39 journals in Gastroenterology & Hepatology on this site (top 50%).
Gastroenterology & Hepatology journals with a similar Impact Factor
- Gastrointestinal Endoscopy IF 8.0
- Hepatology International IF 7.8
- World Journal of Gastroenterology IF 7.7
- United European Gastroenterology Journal IF 6.4
- Liver International IF 6.2
- Journal of Gastroenterology IF 5.7
Author guidelines at a glance
- Case reports
- Not accepted. Explicitly states case reports are not accepted
- Article types
- Original Articles / Systematic Reviews / Meta-analyses / Clinical Trials / Letters
- Abstract
- 250 words (structured)
- OA / APC
- hybrid / – (Main text approx. 12-20 double-spaced pages)
- Reporting guidelines
- CONSORT / STROBE / PRISMA / CARE
- Submission system
- Wiley Research Exchange
About this value
Alimentary Pharmacology & Therapeutics is abbreviated APT. The Journal Impact Factor of Alimentary Pharmacology & Therapeutics (JCR 2025, released June 2026) is 6.8. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Gastroenterology & Hepatology.